Compound Detail
CHEMBL2206196
PAROMOMYCIN SULFATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
Basic Information
| ChEMBL ID | CHEMBL2206196 |
| Name | PAROMOMYCIN SULFATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LJRDOKAZOAKLDU-UDXJMMFXSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL370143 |
| Active Moiety | CHEMBL370143 |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
20
Publications
15
Known Names
5
Indications
1
Mechanisms
Molecular Properties
615.6
MW (Da)
-8.86
ALogP
19
HBA
13
HBD
347.3
PSA (Ų)
0.11
QED
3
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1969 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Bacterial 70S ribosome inhibitor | INHIBITOR | Bacterial 70S ribosome | ✓ | ✓ |
Indications
Amebiasis Infections Leishmaniasis Leishmaniasis, Visceral Osteomyelitis
Activity Summary
IC50 4 meas. best 7.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 50.0 | nM | 7.3 | Inhibition of ribosome S30 subunit-mediated protein synthesis in Escherichia col... | 23148581 |
| Ribosome | IC50 | = | 51.0 | nM | 7.29 | Inhibition of ribosome-mediated translation in prokaryotic system | - |
| Ribosome | IC50 | = | 57000.0 | nM | 4.24 | Inhibition of ribosome-mediated protein synthesis in rabbit reticulocytes after ... | 23148581 |
| Ribosome | IC50 | = | 57000.0 | nM | 4.24 | Inhibition of ribosome-mediated translation in eukaryotic system | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16997553 | 10.1016/j.bmcl.2006.09.013 | Protocadherin-15 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 16997553 | 10.1016/j.bmcl.2006.09.013 | Escherichia coli | 2 |
| - | 10.1039/C0MD00195C | Ribosome | 2 |
| 23148581 | 10.1021/jm3012992 | Unchecked | 2 |
| 16997553 | 10.1016/j.bmcl.2006.09.013 | Bacillus subtilis | 2 |
| 20843939 | 10.1124/dmd.110.035113 | Hepatotoxicity | 1 |
| 20553011 | 10.1021/tx1000865 | Hepatotoxicity | 1 |
| 23148581 | 10.1021/jm3012992 | 80S Ribosome | 1 |
| 23148581 | 10.1021/jm3012992 | Ribosome | 1 |
| 23148581 | 10.1021/jm3012992 | Escherichia coli | 1 |
| 23148581 | 10.1021/jm3012992 | HEK293 | 1 |
| 23571415 | 10.1124/mol.112.084152 | Solute carrier organic anion transporter family member 1B1 | 1 |
| 23571415 | 10.1124/mol.112.084152 | Solute carrier organic anion transporter family member 1B3 | 1 |
| - | 10.1039/C0MD00195C | HEK293 | 1 |
| - | 10.1039/C0MD00195C | HFF | 1 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 1 |
| - | 10.1039/C0MD00195C | Bacillus spizizenii | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine